-
Obeticholic Acid: Practical FXR Workflows
2026-09-10
Build receptor-proximal assays for bile acid regulation, cholestasis, and fibrotic liver phenotypes with Obeticholic Acid. This guide connects validated FXR gene readouts with exploratory immune and fibrosis endpoints while emphasizing formulation control and troubleshooting.
-
Fingolimod (FTY720) in T-Cell Engineering
2026-09-10
Fingolimod (FTY720) gives researchers a pharmacological way to test how S1P signaling, lymphocyte trafficking, and neuroprotective pathways shape immune-cell engineering studies. Paired carefully with the magnetic bispecific nano-antibody strategy from the reference study, it can separate systemic cell-distribution effects from local tumor-targeting effects without implying an unvalidated therapeutic combination.
-
Salinomycin Workflows for HCC Drug-Response Assays
2026-09-09
Build more informative hepatocellular carcinoma assays with Salinomycin by separating growth arrest from true cell killing. This workflow combines viability, apoptosis, calcium, transporter, and Wnt/β-catenin readouts to improve mechanistic interpretation and troubleshooting.
-
Nile Red for Lipid Droplet Imaging
2026-09-09
Nile Red converts intracellular lipid storage into a practical fluorescence readout, with red and green channels that help distinguish membrane-associated signal from lipid-droplet enrichment. This workflow connects lipid droplet imaging with oleic acid stress and autophagy experiments while emphasizing assay controls, channel selection, and troubleshooting.
-
Sex Differences in Angiotensin II Hypertension
2026-09-08
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces a substantially larger hypertensive response in males than in females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex hormone-dependent and autonomic mechanisms, providing a rigorous framework for sex-aware cardiovascular research.
-
LDH Cytotoxicity Assay Kit for Nanomaterial Safety
2026-09-08
Use the LDH Cytotoxicity Assay Kit to quantify membrane damage during nanomaterial screening, magnetic hyperthermia studies, and broader cell cytotoxicity measurement. Its non-radioactive workflow pairs well with controls that distinguish intrinsic material toxicity from heat- or treatment-induced injury.
-
n-Dodecyl-β-D-maltoside for Integrin Cryo-EM
2026-09-07
Discover how n-Dodecyl-β-D-maltoside and DDM condition membrane-protein samples for cryo-EM without treating solubilization as the only endpoint. This article connects detergent chemistry with conformational-ensemble analysis of full-length αvβ3 integrin.
-
Clozapine Workflows for Schizophrenia Research
2026-09-05
Build translational Clozapine experiments around receptor pharmacology, ERK1/2 signaling activation, and prefrontal-circuit models. This workflow also shows how to compare chemical perturbation with selective magnetic stimulation while controlling solubility, timing, and hepatotoxicity confounders.
-
Disodium Bicinchoninate in Oxidative-Stress Assays
2026-09-05
Disodium bicinchoninate brings a water-first design to chelation and protein-normalization workflows, especially when DMSO or ethanol stocks are unsuitable. This guide connects its practical handling to inflammation and oxidative-stress experiments inspired by a biomimetic nanoparticle study, while separating validated product facts from assay-development recommendations.
-
Thiothixene for Reproducible Macrophage Assays
2026-09-04
Learn how Thiothixene (SKU C8719) can support mechanism-informed macrophage efferocytosis, viability, and cytotoxicity workflows. This scenario-based guide covers concentration selection, assay controls, interpretation, handling, and practical vendor evaluation.
-
BRCAness and Olaparib Response in Mesothelioma
2026-09-04
Borchert et al. integrate homologous recombination repair gene-expression profiling with drug-response experiments to identify malignant pleural mesothelioma models that may be vulnerable to olaparib. Their findings connect BAP1-associated BRCAness with increased apoptosis and senescence during PARP inhibition, while also highlighting candidate prognostic markers and the need for biomarker-guided validation.
-
Cdc42–β-Catenin Signaling in Kidney Fibrosis
2026-09-03
The 2024 Advanced Science study identifies daphnepedunin A, a natural diterpenoid from Wikstroemia chamaedaphne, as an anti-fibrotic compound that directly targets Cdc42. Its proposed mechanism links reduced Cdc42 activity to PKCζ/GSK-3β regulation, β-catenin degradation, and reduced fibroblast activation in cellular and unilateral ureteral obstruction models.
-
Stiripentol LDH Inhibitor Research Workflows
2026-09-03
Stiripentol is a research-grade LDH inhibitor that connects astrocyte-neuron lactate shuttle modulation with metabolic and epigenetic assay design. This workflow guide shows how to evaluate lactate flux, histone lactylation, immune-cell function, and seizure-relevant phenotypes while controlling solubility and vehicle-related artifacts.
-
(Z)-4-Hydroxytamoxifen ER Workflow Guide
2026-09-02
Build more interpretable estrogen receptor experiments with (Z)-4-Hydroxytamoxifen, from solvent handling and dose design to orthogonal pathway validation. This guide also shows how delivery, retention, and genetic-control principles from a cartilage nanoparticle study can sharpen breast cancer assay logic without overstating cross-domain evidence.
-
DOT1L Reprograms Immunity in Multiple Myeloma
2026-09-02
The 2025 Cancer Letters study shows that DOT1L inhibition activates STING-linked innate immune signaling and disrupts oncogenic transcriptional programs in multiple myeloma. Its combination with lenalidomide strengthens interferon-regulated gene expression and suppresses IRF4–MYC signaling, providing a mechanistic rationale for epigenetic–immunomodulatory drug combinations.